Penserra Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,100
| Closed | -$58K | – | 1383 |
|
|
2021
Q3 | $58K | Buy |
4,100
+55
| +1% | +$778 | ﹤0.01% | 1007 |
|
|
2021
Q2 | $63K | Buy |
4,045
+45
| +1% | +$701 | ﹤0.01% | 936 |
|
|
2021
Q1 | $40K | Sell |
4,000
-120
| -3% | -$1.2K | ﹤0.01% | 846 |
|
|
2020
Q4 | $30K | Buy |
4,120
+2,614
| +174% | +$19K | ﹤0.01% | 775 |
|
|
2020
Q3 | $5K | Buy |
+1,506
| New | +$5K | ﹤0.01% | 858 |
|